A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
This is a study evaluating the efficacy and safety of calderasib with pembrolizumab as first-line treatment in participants with locally advanced or metastatic non-small cell lung cancer (NSCLC) with identified Kirsten rat sarcoma viral oncogene homolog G12C (KRAS G12C) mutation and programmed cell death ligand 1 (PD-L1) tumor proportion score (TPS) ≥50%. There are two primary study hypotheses: Hypothesis 1: Combination of calderasib and pembrolizumab is superior to placebo plus pembrolizumab with respect to progression free survival (PFS) per Response Evaluation Criteria in Solid Tumors Version 1.1 (RECIST 1.1) by blinded independent central review (BICR). Hypothesis 2: Combination of calderasib plus pembrolizumab is superior to placebo plus pembrolizumab with respect to overall survival (OS).
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Potwierdzony rozpoznanie raka płuc (typ niśćisto-drobiazgowy)
- •Zaawansowany stadium raka (III lub IV) niekwalifikujący się do operacji lub chemioterapii
- •Pobranie próbki guza do badania mutacji KRAS G12C i innego profilu genetycznego
- •Wyleczenie z wcześniejszych efektów ubocznych poprzednich leczeń raka
- •Jeśli chory na HIV - kontrolowana infekcja na lekach
- •Jeśli nosiciel wirusa hepatitis B - leczone i niewykrywalne wirusy w krwi
- •Jeśli było zakażenie hepatitis C - niewykrywalne wirusy w krwi
✗ Disqualifies
- •Rozpoznanie raka płuc typu drobiazgowego
- •Aktywne zapalenie jelita wymaga leków immunosupresyjnych
- •Historia zaburzeń nerwowych związanych z nowotworem
- •Aktywne zakażenie wymagające leków przeciwbakteryjnych
- •Niekontrolowana choroba serca lub mózgu
- •Wysokie ciśnienie wewnątrz oka (>21 mmHg) lub jaskra
- •Diagnoza obrzęku plamki żółtej sieci naczyniówki oka
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Last updated (source)
- October 7, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (241)
CBCC Global Research, Inc. ( Site 0123)
Bakersfield, United States
Beverly Hills Cancer Center ( Site 0116)
Beverly Hills, United States
Stamford Hospital ( Site 0136)
Stamford, United States
Mount Sinai Cancer Center ( Site 0137)
Miami Beach, United States
Orchard Healthcare Research Inc. ( Site 0115)
Skokie, United States
Truman Medical Center ( Site 0126)
Kansas City, United States
Cox Medical Center North ( Site 0133)
Springfield, United States
St. Vincent Frontier Cancer Center-Research ( Site 0105)
Billings, United States
Atlantic Health System Morristown Medical Center ( Site 0121)
Morristown, United States
New York Oncology Hematology, P.C. ( Site 0132)
Albany, United States
University of Cincinnati Medical Center-University of Cincinnati Cancer Center ( Site 0103)
Cincinnati, United States
Kettering Health Main Campus-Kettering Health Cancer Center ( Site 0106)
Kettering, United States
Lancaster General Hospital - Ann B Barshinger Cancer Institute ( Site 0134)
Lancaster, United States
Oncology Consultants P.A. ( Site 0113)
Houston, United States
Circuit Clinical/SSM Health Dean Medical Group ( Site 0129)
Madison, United States
Centro de Oncología e Investigación de Buenos Aires ( Site 0308)
Berazategui, Argentina
AUSTRAL MEDICAL CENTER ( Site 0302)
CABA, Argentina
Centro Oncologico Korben ( Site 0304)
CABA, Argentina
Instituto de Investigaciones Clínicas Mar del Plata ( Site 0300)
Mar del Plata, Argentina
Clinica Viedma S. A ( Site 0307)
Viedma, Argentina
Fundacion Estudios Clinicos ( Site 0306)
Rosario, Argentina
Sanatorio Parque ( Site 0301)
Rosario, Argentina
Chris O'Brien Lifehouse ( Site 3000)
Camperdown, Australia
Cancer Care Service Hervey Bay ( Site 3003)
Urraween, Australia
Frankston Hospital ( Site 3002)
Frankston, Australia
One Clinical Research ( Site 3001)
Nedlands, Australia
Medizinische Universität Graz-Klinische Abteilung für Pulmonologie ( Site 2401)
Graz, Austria
Klinik Floridsdorf-Abteilung für Innere Medizin und Pneumologie ( Site 2400)
Vienna, Austria
Hospital Mario Penna ( Site 0436)
Belo Horizonte, Brazil
Hospital de Câncer de Recife ( Site 0447)
Recife, Brazil
Oncoclínica Oncologistas Associados ( Site 0441)
Teresina, Brazil
Liga Norte Riograndense Contra o Câncer ( Site 0439)
Natal, Brazil
Hospital de Caridade de Ijuí ( Site 0438)
Ijuí, Brazil
Hospital de Clínicas de Passo Fundo ( Site 0442)
Passo Fundo, Brazil
Irmandade da Santa Casa de Misericórdia de Porto Alegre-Centro Multidisciplinar de Pesquisa Clínica ( Site 0435)
Porto Alegre, Brazil
Fundação Pio XII - Hospital de Câncer de Barretos-Unidade de Pesquisa Clínica ( Site 0437)
Barretos, Brazil
Instituto Nacional de Câncer - INCA ( Site 0446)
Rio de Janeiro, Brazil
Americas ( Site 0431)
Rio de Janeiro, Brazil
MBAL Uni Hospital-Department of Medical Oncology ( Site 1000)
Panagyurishte, Bulgaria
Multiprofile Hospital for Active Treatment SerdikaМЕD EOOD-Second Department of Medical Oncology ( Site 1002)
Sofia, Bulgaria
MHAT - Heart and Brain ( Site 1006)
Pleven, Bulgaria
Medical Center Futuremeds ( Site 1007)
Plovdiv, Bulgaria
Complex Oncology Center - Plovdiv EOOD ( Site 1003)
Plovdiv, Bulgaria
CancerCare Manitoba ( Site 0210)
Winnipeg, Canada
QEII Health Sciences Centre - Victoria General Site-Dept. of Medical Oncology ( Site 0208)
Halifax, Canada
Hamilton Health Sciences-Juravinski Cancer Centre ( Site 0205)
Hamilton, Canada
Sunnybrook Research Institute ( Site 0206)
Toronto, Canada
St. Marys Hospital Center ( Site 0204)
Montreal, Canada
Centre integre universitaire de sante et de services sociaux de la Mauricie-et-du-centre-du-quebec ( Site 0207)
Trois-Rivières, Canada
Clinica Universidad Catolica del Maule-Oncology ( Site 0500)
Talca, Chile
Orlandi Oncologia-Oncology ( Site 0503)
Santiago, Chile
FALP-UIDO ( Site 0501)
Santiago, Chile
Centro de Oncología de Precisión ( Site 0502)
Santiago, Chile
Bradfordhill-Clinical Area ( Site 0504)
Santiago, Chile
Anhui Provincial Cancer Hospital ( Site 3136)
Hefei, China
Beijing Cancer hospital ( Site 3133)
Beijing, China
Beijing Cancer hospital ( Site 3134)
Beijing, China
Beijing Peking Union Medical College Hospital-pneumology department ( Site 3102)
Beijing, China
Beijing Chest Hospital,Capital Medical University ( Site 3104)
Beijing, China
Chongqing University Cancer Hospital ( Site 3119)
Chongqing, China
Army Medical Center of People's Liberation Army ( Site 3142)
Chongqing, China
Fujian Cancer Hospital ( Site 3127)
Fuzhou, China
The First Affiliated hospital of Xiamen University ( Site 3148)
Xiamen, China
The First Affiliated Hospital of Guangzhou Medical University ( Site 3108)
Guangzhou, China
Southern Medical University Nanfang Hospital ( Site 3128)
Guangzhou, China
Sun Yat-sen University Cancer Center ( Site 3137)
Guangzhou, China
Harbin Medical University Cancer Hospital ( Site 3123)
Harbin, China
JIAMUSI TUBERCULOSIS HOSPITAL(CANCER HOSPITAL) ( Site 3124)
Jiamusi, China
Henan Cancer Hospital ( Site 3149)
Zhengzhou, China
Tongji Hospital Tongji Medical,Science & Technology ( Site 3113)
Wuhan, China
Hubei Cancer Hospital ( Site 3126)
Wuhan, China
The Second Xiangya Hospital of Central South University ( Site 3130)
Changsha, China
Hunan Cancer Hospital ( Site 3141)
Changsha, China
Nanjing Gulou Hospital ( Site 3122)
Nanjing, China
Nanjing First Hospital ( Site 3154)
Nanjing, China
The First Affiliated Hospital of Soochow University ( Site 3146)
Suzhou, China
Affiliated Hospital of Jiangnan University(Wuxi Fourth People's Hospital ) ( Site 3155)
Wuxi, China
The Second Affiliated Hospital of Nanchang University ( Site 3139)
Nanchang, China
The First affiliated hospital of Nanchang University (Xianghu campus) ( Site 3138)
Nanchang, China
Jilin Province Tumor Hospital ( Site 3107)
Changchun, China
The First Affiliated Hospital of Xi'an Jiaotong University ( Site 3150)
Xi'an, China
Shandong Cancer Hospital ( Site 3116)
Jinan, China
LinYi Cancer Hospital ( Site 3111)
Linyi, China
Shanghai Chest Hospital ( Site 3100)
Shanghai, China
Fudan University Shanghai Cancer Center ( Site 3144)
Shanghai, China
Zhongshan Hospital,Fudan University ( Site 3143)
Shanghai, China
Shanxi Cancer Hospital ( Site 3131)
Taiyuan, China
The Second Affiliated Hospital of Air Force Medical University ( Site 3117)
Xian, China
The Second Affiliated Hospital of Air Force Medical University ( Site 3152)
Xian, China
West China Hospital, Sichuan University ( Site 3140)
Chengdu, China
The Third People's Hospital of Chengdu (CDTPH) ( Site 3157)
Chengdu, China
Sichuan Cancer hospital. ( Site 3109)
Chengdu, China
The Second People's Hospital of Neijiang ( Site 3105)
Neijiang, China
Xinjiang Medical University Cancer Hospital - Urumqi ( Site 3101)
Ürümqi, China
Yunnan Province Cancer Hospital ( Site 3153)
Kunming, China
The first Affiliated Hospital, Zhejiang University School of Medicine ( Site 3115)
Hangzhou, China
Sir Run Run Shaw Hospital of Zhejiang University School of Medicine ( Site 3121)
Hangzhou, China
Taizhou Hospital of Zhejiang Province ( Site 3145)
Linhai, China
The First Affiliated Hospital of Wenzhou Medical University ( Site 3151)
Wenzhou, China
Sociedad De Oncología y Hematología Del Cesar SAS ( Site 4000)
Valledupar, Colombia
Clinica Oncologica Colsubsidio ( Site 4003)
Bogota, Colombia
Oncologos del Occidente ( Site 4005)
Pereira, Colombia
Hemato Oncologos SA ( Site 4002)
Cali, Colombia
Onco Tech, S.A. ( Site 4102)
San José, Costa Rica
Centre Hospitalier Universitaire de Nice - Hopital Pasteur ( Site 1108)
Nice, France
Centre Hospitalier Universitaire Dijon Bourgogne - Hôpital François Mitterrand ( Site 1103)
Dijon, France
Centre Hospitalier Universitaire de Nîmes - Institut de Cancérologie du Gard - Hôpital Universitaire ( Site 1106)
Nîmes, France
Clinique Teissier Groupe ( Site 1100)
Valenciennes, France
Centre Jean Perrin - Centre Régional de Lutte contre le Cancer d'Auvergne-ONCOLOGY ( Site 1101)
Clermont-Ferrand, France
Centre Hospitalier d'Avignon-Service d'Oncologie médicale et d'hématologie clinique ( Site 1104)
Avignon, France
Hôpital Ambroise Paré-Department of Respiratory Diseases and Thoracic Oncology ( Site 1105)
Boulogne-Billancourt, France
High Technology Hospital Medcenter ( Site 1203)
Batumi, Georgia
Caucasus Medical Centre ( Site 1202)
Tbilisi, Georgia
American Hospital Network LLC ( Site 1208)
Tbilisi, Georgia
Todua Clinic, LLC ( Site 1204)
Tbilisi, Georgia
TSMU and Ingorokva High Medical Technology University Clinic LTD ( Site 1201)
Tbilisi, Georgia
New Hospitals ( Site 1200)
Tbilisi, Georgia
Cancer Research Centre. Mardaleishvili Medical Centre ( Site 1205)
Tbilisi, Georgia
Tbilisi Institute of Medicine ( Site 1206)
Tbilisi, Georgia
Marienhospital Stuttgart ( Site 1302)
Stuttgart, Germany
Universitätsmedizin Greifswald ( Site 1308)
Greifswald, Germany
Evangelisches Krankenhaus Bielefeld - Johannesstift ( Site 1307)
Bielefeld, Germany
Krankenhaus Bethanien ( Site 1303)
Solingen, Germany
UNIVERSITY HOSPITAL OF PATRAS-DIVISION OF ONCOLOGY ( Site 1402)
Pátrai, Greece
Agios Savvas Regional Cancer Hospital-2nd Medical Oncology Department ( Site 1407)
Athens, Greece
THORACIC GENERAL HOSPITAL OF ATHENS "I SOTIRIA"-3rd Dept of Internal Medicine and Laboratory, Oncol ( Site 1400)
Athens, Greece
Athens Medical Center ( Site 1406)
Marousi, Greece
University General Hospital of Larissa-Oncology Clinic ( Site 1403)
Larissa, Greece
European Interbalkan Medical Center ( Site 1404)
Thessaloniki, Greece
G. Papanikolaou General Hospital-Pulmonary Clinic of Aristotle University of Thessaloniki ( Site 1405)
Thessaloniki, Greece
Sir H. N. Reliance Foundation Hospital and Research Centre ( Site 3201)
Mumbai, India
Tata Memorial Hospital ( Site 3205)
Mumbai, India
AIIMS New Delhi Dept of Medicine ( Site 3206)
New Delhi, India
Indraprastha Apollo Hospitals-APOLLO RESEARCH INNOVATION ( Site 3203)
New Delhi, India
Istituto Nazionale Tumori IRCCS Fondazione Pascale-Oncologia clinica sperimentale Toraco-Polmonare ( Site 1607)
Naples, Italy
Ospedale Santa Maria delle Croci ( Site 1606)
Ravenna, Italy
CRO-IRCCS-Clinical Oncology ( Site 1605)
Aviano, Italy
Fondazione Policlinico Universitario Agostino Gemelli IRCCS -Medical Oncology ( Site 1601)
Rome, Italy
Fondazione IRCCS Istituto Nazionale dei Tumori-Struttura Complessa Oncologia Medica 1 ( Site 1600)
Milan, Italy
Istituto Europeo di Oncologia IRCCS-Divisione di Oncologia Toracica ( Site 1604)
Milan, Italy
A.O.R.N. Ospedale dei Colli - Monaldi V.-U.O.C Pneumologia Oncologica DH PNL ONC ( Site 1602)
Naples, Italy
Istituto Nazionale Tumori Regina Elena-Oncologia Medica 2 ( Site 1609)
Rome, Italy
Azienda USL Toscana Nord Ovest_Ospedale Civile di Livorno-UOC Oncologia Medica Livorno ( Site 1608)
Livorno, Italy
IOV - Istituto Oncologico Veneto IRCCS UOSD - Unità di ricerca clinica ( Site 1603)
Padova, Italy
Nagoya University Hospital ( Site 3309)
Nagoya, Japan
Fujita Health University Hospital ( Site 3310)
Toyoake, Japan
National Cancer Center Hospital East ( Site 3303)
Kashiwa, Japan
National Hospital Organization Shikoku Cancer Center ( Site 3315)
Matsuyam, Japan
National Hospital Organization Kyushu Cancer Center ( Site 3316)
Fukuoka, Japan
Kurume University Hospital ( Site 3317)
Kurume, Japan
Gunma Prefectural Cancer Center ( Site 3302)
Ōta, Japan
Sapporo Medical University Hospital ( Site 3324)
Sapporo, Japan
Kanazawa University Hospital ( Site 3308)
Kanazawa, Japan
St. Marianna University Hospital ( Site 3320)
Kawasaki, Japan
Saiseikai Matsusaka Municipal Hospital ( Site 3311)
Matsusaka, Japan
Miyagi Cancer Center ( Site 3301)
Natori-shi, Japan
Sendai Kousei Hospital ( Site 3300)
Sendai, Japan
Kansai Medical University Hospital ( Site 3312)
Hirakata, Japan
Osaka Medical and Pharmaceutical University Hospital ( Site 3313)
Takatsuki, Japan
Saitama Prefectural Cancer Center ( Site 3304)
Kitaadachi-gun, Japan
Nippon Medical School Hospital ( Site 3306)
Bunkyo, Japan
Toho University Omori Medical Center ( Site 3319)
Ōta-ku, Japan
Tokyo Medical University Hospital ( Site 3307)
Shinjuku, Japan
National Center for Global Health and Medicine ( Site 3305)
Shinjuku, Japan
Chiba University Hospital ( Site 3322)
Chiba, Japan
Hiroshima City Hiroshima Citizens Hospital ( Site 3314)
Hiroshima, Japan
Saiseikai Kumamoto Hospital ( Site 3318)
Kumamoto, Japan
Niigata University Medical & Dental Hospital ( Site 3323)
Niigata, Japan
Osaka Metropolitan University Hospital ( Site 3321)
Osaka, Japan
Arké SMO S.A. de C.V. ( Site 0602)
Mexico City, Mexico
Hospital Universitario "Dr. Jose Eleuterio Gonzalez"-Hematologia and Oncologia ( Site 0600)
Monterrey, Mexico
Oaxaca Site Management Organization S.C. ( Site 0603)
Oaxaca City, Mexico
Ziekenhuis Gelderse Vallei ( Site 1705)
Ede, Netherlands
Ziekenhuis St. Jansdal-Poli Longziekten ( Site 1701)
Harderwijk, Netherlands
Ziekenhuisgroep Twente, locatie Almelo ( Site 1706)
Hengelo, Netherlands
Isala, locatie Zwolle-Poli Longziekten ( Site 1700)
Zwolle, Netherlands
Universitair Medisch Centrum Utrecht ( Site 1704)
Utrecht, Netherlands
Auckland City Hospital ( Site 3400)
Auckland, New Zealand
IPOR Instituto Peruano de Oncología & Radioterapia ( Site 4301)
Lima, Peru
The Medical City ( Site 3507)
Pasig, Philippines
Lung Center of the Philippines-Pulmonary, Critical Care and Sleep Medicine ( Site 3503)
Quezon City, Philippines
Veterans Memorial Medical Center-Section of Oncology ( Site 3505)
Quezon City, Philippines
ST. LUKE'S MEDICAL CENTER-Medical oncology ( Site 3501)
Quezon City, Philippines
Szpital Specjalistyczny im. Henryka Klimontowicza ( Site 1801)
Gorlice, Poland
Pratia MCM Krakow ( Site 1808)
Krakow, Poland
Uniwersytecki Szpital Kliniczny nr 4 w Lublinie ( Site 1805)
Lublin, Poland
Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - P-Klinika Nowotworow Pluca i Klatki Pier ( Site 1800)
Warsaw, Poland
Wojewodzki Szpital im. Sw. Ojca Pio w Przemyslu ( Site 1804)
Przemyśl, Poland
Warminsko-Mazurskie Centrum Chorob Pluc w Olsztynie ( Site 1809)
Olsztyn, Poland
Centrul de Diagnostic si Tratament Provita. ( Site 1992)
Bucharest, Romania
Centrul de Oncologie Sfantul Nectarie-Medical ( Site 1994)
Craiova, Romania
Cabinet Medical Oncomed ( Site 1998)
Timișoara, Romania
SC ONCO CARD SRL ( Site 1995)
Brasov, Romania
SC MNT HEALTHCARE EUROPE SRL ( Site 1991)
Bucharest, Romania
Institutul Oncologic Cluj-Oncologie Medicala ( Site 1999)
Cluj-Napoca, Romania
Sigmedical Services SRL ( Site 1997)
Suceava, Romania
The Catholic University of Korea, Incheon St. Mary's Hospital ( Site 3606)
Bupyeong-gu, South Korea
Chonnam National University Hwasun Hospital-Pulmonology ( Site 3604)
Hwasun, South Korea
The Catholic University Of Korea St. Vincent's Hospital-Medical Oncology ( Site 3600)
Suwon, South Korea
Pusan National University Yangsan Hospital-Lung Cancer Clinic ( Site 3603)
Yangsan, South Korea
Yeungnam University Hospital ( Site 3607)
Daegu, South Korea
Keimyung University Dongsan Hospital ( Site 3611)
Daegu, South Korea
Chungnam national university hospital ( Site 3602)
Junggu, South Korea
Inha University Hospital ( Site 3610)
Incheon, South Korea
Kyung Hee University Hospital ( Site 3605)
Seoul, South Korea
Korea University Anam Hospital ( Site 3609)
Seoul, South Korea
The Catholic University of Korea, Eunpyeong St. Mary's Hospital ( Site 3608)
Seoul, South Korea
Korea University Guro Hospital ( Site 3601)
Seoul, South Korea
Hospital Insular de Gran Canaria-Oncology ( Site 2019)
Las Palmas de Gran Canaria, Spain
Hospital Universitario Severo Ochoa ( Site 2024)
Leganés, Spain
HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑON-ONCOLOGY ( Site 2012)
Madrid, Spain
H.R.U Málaga - Hospital General-Oncology ( Site 2014)
Málaga, Spain
Hospital Universitari Vall d Hebron ( Site 2010)
Barcelona, Spain
Hospital Universitario La Princesa ( Site 2020)
Madrid, Spain
Hospital Universitario Fundación Jiménez Díaz-Oncology & Hematology ( Site 2017)
Madrid, Spain
Hospital Universitario Virgen de la Victoria ( Site 2021)
Málaga, Spain
Hospital Universitario Virgen Macarena-Unidad de Investigación Oncológica ( Site 2015)
Seville, Spain
Dokuz Eylul Universitesi Hastanesi ( Site 2108)
Balçova, Turkey (Türkiye)
Ege Universitesi Hastanesi-Chest Diseases Department ( Site 2102)
Bornova, Turkey (Türkiye)
Adana Medical Park Seyhan Hastanesi-Medikal Onkoloji ( Site 2107)
Adana, Turkey (Türkiye)
SBU GULHANE EGITIM VE ARASTIRMA HASTANESI Onkoloji ( Site 2104)
Ankara, Turkey (Türkiye)
Hacettepe Universite Hastaneleri-oncology hospital ( Site 2101)
Ankara, Turkey (Türkiye)
Memorial Ankara Hastanesi-Medical Oncology ( Site 2106)
Ankara, Turkey (Türkiye)
Ankara Bilkent Şehir Hastanesi ( Site 2100)
Ankara, Turkey (Türkiye)
Medipol Mega Universite Hastanesi-oncology ( Site 2105)
Istanbul, Turkey (Türkiye)
TC Saglik Bakanligi Goztepe Prof. Dr. Suleyman Yalcin Sehir Hastanesi-oncology ( Site 2103)
Istanbul, Turkey (Türkiye)
Sakarya Training and Research Hospital ( Site 2109)
Sakarya, Turkey (Türkiye)
COMMUNAL NONPROFIT ENTERPRISE CLINICAL CENTER OF ONCOLOGY, HEMATOLOGY, TRANSPLANTOLOGY AND PALLIATI ( Site 2209)
Cherkasy, Ukraine
Regional Municipal Non-profit Enterprise "Bukovinian Clinical Oncology Center" ( Site 2210)
Chernivtsi, Ukraine
Medical Center "Mriya Med-Service"-Clinical Research Department ( Site 2215)
Kryvyi Rih, Ukraine
Communal Non-Commercial Enterprise "Prykarpatski Clinical On-Surgery department #2 ( Site 2202)
Ivano-Frankivsk, Ukraine
Kirovohrad Regional Oncology Center-Chemotherapy department ( Site 2204)
Kropyvnytskyi, Ukraine
Medical Center "MedOffice Group" ( Site 2219)
Kiev, Ukraine
LLC Clinic Verum Expert ( Site 2223)
Kyiv, Ukraine
Lviv Territorial Medical Union Multidisciplinary Clinical Hospital ( Site 2217)
Lviv, Ukraine
Rivne Regional Clinical Hospital ( Site 2205)
Rivne, Ukraine
ME RIVNE REGIONAL ANTITUMOR CENTER ( Site 2920)
Rivne, Ukraine
Communal Noncommercial Enterprise "Podillia Regional Oncolog-Cardiothoracic department ( Site 2211)
Vinnytsia, Ukraine
ME Volyn Regional Clinical Hospital of the Volyn Regional Council ( Site 2216)
Lutsk, Ukraine
Milton Keynes Hospital ( Site 2304)
Milton Keynes, United Kingdom
Royal Devon & Exeter Hospital-Oncology ( Site 2302)
Exeter, United Kingdom
Trial contact
Toll Free Number
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 9/9/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.